Finance

Beta
Lists
CVSH34:BVMF
Cvs Health Corporation BDR
46,40 BRL
+2,52%
(+1,14) 1D
3-июн., 16:56:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for CVSH34...
Open
47,00 BRL
High
47,43 BRL
Low
46,40 BRL
Mkt. cap
116,58 млд
Avg. vol.
405,00
Volume
2,06 миң
52-wk high
48,84 BRL
52-wk low
31,79 BRL
Shares outstanding
1,28 млд
No. of employees
260 миң
Open
47,00 BRL
High
47,43 BRL
Low
46,40 BRL
Mkt. cap
116,58 млд
Avg. vol.
405,00
Volume
2,06 миң
52-wk high
48,84 BRL
52-wk low
31,79 BRL
Shares outstanding
1,28 млд
No. of employees
260 миң
News stories
From sources across the web
Profile
CVS Health Corporation is an American multinational healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands. The company is the world's second largest healthcare company, behind UnitedHealth Group. In 2023, the company was ranked 64th in the Forbes Global 2000. CVS started in Lowell, Massachusetts by brothers Stanley and Sidney Goldstein and their partner Ralph Hoagland. The name stood for Consumer Value Stores. Wikipedia
About Cvs Health Corporation BDR
CEODavid Joyner
Employees260 миң
Founded1963
HeadquartersВунсокет, Род Айленд, Америка Кошмо Штаттары
SectorHealth care provider
Websitecvshealth.com
Last report
2026-ж., 6-май
Fiscal period
Q1 2026
EPS / Est. (USD)
2,57 USD / 2,21 USD
+16,48%beat
Revenue / Est. (USD)
99,85 млд / 95,02 млд
+5,09%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
Revenue
98,43 млд
102,24 млд
105,10 млд
99,85 млд
Cost of goods sold
85,32 млд
89,06 млд
92,13 млд
84,80 млд
Cost of revenue
85,32 млд
89,06 млд
92,13 млд
84,80 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,35 млд
10,86 млд
11,32 млд
10,93 млд
Operating expense
10,35 млд
10,86 млд
11,32 млд
10,93 млд
Total operating expenses
95,67 млд
99,92 млд
103,45 млд
95,73 млд
Operating income
2,76 млд
2,32 млд
1,65 млд
4,12 млд
Other non operating income
29,00 млн
26,00 млн
-88,00 млн
32,00 млн
EBT including unusual items
1,65 млд
-3,48 млд
1,35 млд
3,94 млд
EBT excluding unusual items
2,51 млд
2,19 млд
1,37 млд
3,95 млд
Income tax expense
634,00 млн
508,00 млн
-1,57 млд
981,00 млн
Effective tax rate
38,49%
-14,59%
-115,88%
24,91%
Other operating expenses
-
-
-
-
Net income
1,02 млд
-3,98 млд
2,94 млд
2,94 млд
Net profit margin
1,04%
-3,89%
2,80%
2,95%
Earnings per share
1,81
1,60
1,09
2,57
Interest and investment income
487,00 млн
632,00 млн
594,00 млн
574,00 млн
Interest expense
-763,00 млн
-784,00 млн
-787,00 млн
-774,00 млн
Net interest expenses
-276,00 млн
-152,00 млн
-193,00 млн
-200,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
3,93 млд
3,45 млд
2,80 млд
5,23 млд
Gain or loss from assets sale
-
-483,00 млн
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer